Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Perineuronal nets (PNNs) are specialized, lattice-like extracellular matrix structures that encapsulate the cell bodies and proximal dendrites of specific neurons, most notably parvalbumin-expressing (PV) inhibitory interneurons (Sorg et al., 2016, Chemical Reviews). Composed of a scaffold of hyaluronan, chondroitin sulfate proteoglycans (CSPGs), link proteins, and tenascin-R, PNNs act as a physical and chemical barrier that stabilizes synapses and marks the end of developmental critical periods (Pizzorusso et al., 2002, Science). By restricting structural plasticity, they maintain the stability of neural circuits but also limit the brain's ability to recover from injury or adapt to new information in adulthood. In pathological contexts, PNNs are often degraded in schizophrenia and Alzheimer's disease, contributing to cognitive dysfunction, while their persistence in spinal cord injury and PTSD prevents axonal regeneration and the extinction of traumatic memories (Berretta et al., 2015, Frontiers in Integrative Neuroscience). Therapeutic strategies targeting PNNs involve the use of enzymes like chondroitinase ABC to digest CSPGs or small molecules like 4-methylumbelliferone to inhibit their synthesis, thereby 'reopening' windows of plasticity for functional rehabilitation and memory modulation (Bradbury & Burnside, 2019, Nature Reviews Neuroscience).
Enzymatic degradation of chondroitin sulfate proteoglycans (CSPGs) or inhibition of hyaluronan/CSPG synthesis to reduce PNN density and restore neuroplasticity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Perineuronal nets (PNNs).